Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Hyung Kim, MD, Cedars-Sinai Medical Center, Los Angeles, CA, discusses how useful immunotherapy is for the treatment of kidney cancer, especially in the adjuvant setting. This interview took place at the American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium 2022 in San Francisco, CA.